Catalent Pharma Solutions offers its partners end-to-end solutions, from drug formulation and drug delivery technologies, to manufacturing and clinical supply services.
Catalent Pharma Solutions offers its partners end-to-end solutions, from drug formulation and drug delivery technologies, to manufacturing and clinical supply services. Each molecule has unique characteristics, and Catalent offers partners its formulation and development experience, and a wide range of tools and technologies to create innovative, intelligent dose forms to overcome challenges, while making better products for patients.
Catalent Pharma Solutions
14 Schoolhouse Rd, Somerset, NJ 08873
tel. 1.888.SOLUTION
solutions@catalent.com
AAPS Booth Number: 1727
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.